People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn’s disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average.
European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients – Psychedelic Alpha
Psilocybin therapy has shown promise in improving psycho-spiritual wellbeing in patients with life-threatening cancer, as demonstrated by Griffiths et al. (2016), Shnayder et al. (2023),